Form 4: 10x Genomics Former CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Former CFO of 10x Genomics, Justin J. McAnear, sold shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On August 22, 2024, Justin J. McAnear, former Chief Financial Officer of 10x Genomics, Inc., sold 2,961 shares of Class A Common Stock.
- The sale was executed at a price of $22.5297 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, McAnear directly owns 143,242 shares of 10x Genomics, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a stock sale to cover tax obligations, which is a routine transaction.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders. Such filings are common for publicly traded companies and are mandated by the SEC.
Stakeholder Impact
- The sale of shares by a former executive could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 08/22/2024 | Date of the transaction: Justin J. McAnear sold 2,961 shares of Class A Common Stock. |
| 08/26/2024 | Date of signature on the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.